MICHAEL MIKOLA: Open Payments
NPI 1013969393 · MT PLEASANT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 9 payments from 6 companies in 2025. Trend: 2023 $146 · 2024 $409 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $152 |
| AstraZeneca Pharmaceuticals LP | 1 | $109 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $105 |
| ABBVIE INC. | 2 | $35 |
| TOLMAR, INC. | 1 | $22 |
| Amgen Inc. | 1 | $19 |
Products named: Ozempic, BREZTRI, XIFAXAN, Wegovy, JATENZO, REPATHA, VRAYLAR, UBRELVY.
Industry payments across SC — which companies pay providers there.
